Skip to main content

Table 2 Association between medicine retailer knowledge, behaviours and study outcomes

From: Geographically-weighted regression of knowledge and behaviour determinants to anti-malarial recommending and dispensing practice among medicine retailers in western Kenya: capacitating targeted interventions

  % (n) Unadjusted odds ratios and (95% confidence intervals; p-values)
Recommended ACTs as malaria treatment for adult patients Recommended ACTs as malaria treatment for under 5 patients Reported selling ACTs more than any other antimalarial
Identified ACT as MOH-recommended antimalarial
 No 37% (32) 1 (reference) 1 (reference) 1 (reference)
 Yes 63% (55) 3.0 (1.21–7.47; 0.018)** 2.34 (0.93–5.88; 0.070)* 2.36 (0.92–6.03; 0.073)*
Recommended ACT to adults
 No 45% (39) 1 (reference) 1 (reference)
 Yes 55% (48) 5.37 (2.08–13.87; 0.001)** 8.89 (3.11–25.39; < 0.001)**
Recommended ACT to children
 No 55% (48) 1 (reference) 1 (reference)
 Yes 45% (39) 5.37 (2.08–13.87; 0.001)** 3.76 (1.52–9.28; 0.004)**
Sold ACTs more than any other antimalarial
 No 59% (51) 1 (reference) 1 (reference)
 Yes 41% (36) 8.89 (3.11–25.39; < 0.001)** 3.76 (1.52–9.28; 0.004)**
Gave Fansidar to a mother requesting it
 No 81% (70) 1 (reference) 1 (reference) 1 (reference)
 Yes 18% (16) 0.67 (0.21–2.01; 0.461) 0.36 (0.11–1.25; 0.109)* 0.94 (0.30–2.94; 0.919)
  1. * Significant at p < 0.2
  2. ** Significant at p < 0.05